FDA Approves Oral Combination of Decitabine and Cedazuridine Tablets with Venetoclax for Newly Diagnosed AML By Ogkologos - June 3, 2026 39 0 Facebook Twitter Google+ Pinterest WhatsApp Evidence for efficacy is based on the results from the Study ASTX727-07 Source RELATED ARTICLESMORE FROM AUTHOR High HPV Vaccination Coverage in England Associated with a Substantial Reduction in Cervical Cancer Mortality FDA Approves Datopotamab Deruxtecan-dlnk for Unresectable or Metastatic TNBC Oral Sunvozertinib Prolongs PFS Over Chemotherapy as First-Line Treatment for Patients with Advanced NSCLC with EGFR Exon 20 Insertions MOST POPULAR Moxetumomab Approved by FDA for Hairy Cell Leukemia September 14, 2018 EMA Recommends Extension of Indications for Dostarlimab January 23, 2025 EMA Recommends Granting a Marketing Authorisation for Crisantaspase September 7, 2023 Steps towards a smokefree society August 31, 2022 Load more HOT NEWS Cancer in My Community: Caring for Children With Cancer in Armenia Volunteering with Pride: Brett’s award-winning involvement with Cancer Research UK Dormant Tumor Cells Can Be Sensitized to Chemotherapy A Better Biomarker for Cancer Immunotherapy?
